TC

Triskelion Capital

North America, New York, United States, New York

Description

Triskelion Capital is an investment firm that focuses business quality and management's capital allocation.

Investor Profile

Triskelion Capital has made 2 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series A (50%)
  • Seed (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Emergency Medicine
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Triskelion Capital frequently co-invest with?

Kairos Ventures
North America, California, United States, Beverly Hills
Co-Investments: 1
Emerald Development Managers
North America, New York, United States, New York
Co-Investments: 1
TEDCO
North America, Maryland, United States, Columbia
Co-Investments: 1
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 1
Ginkgo Gofar Group
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Camden Partners
North America, Maryland, United States, Baltimore
Co-Investments: 1
AngelMD
North America, Colorado, United States, Denver
Co-Investments: 1
Abell Foundation
North America, Maryland, United States, Baltimore
Co-Investments: 1
Nexus Capital Management
North America, California, United States, Los Angeles
Co-Investments: 1
Medytox
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by Triskelion Capital?

Lifesprout

Baltimore, Maryland, United States

LifeSprout offers revolutionary products for soft tissue replacement and regeneration

BiotechnologyEmergency MedicineHealth CareMedical
Series AApr 27, 2020
Amount Raised: $28,500,000
Lifesprout

Baltimore, Maryland, United States

LifeSprout offers revolutionary products for soft tissue replacement and regeneration

BiotechnologyEmergency MedicineHealth CareMedical
SeedJun 18, 2018
Amount Raised: $6,500,000